Beam Therapeutics vs Cassidy Bio
Beam Therapeutics vs Cassidy Bio, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Beam Therapeutics is on 47/100 and Cassidy Bio on 55/100.
Where each one leads
Beam Therapeutics
- funding raised: $235M against $20.0M
Cassidy Bio
- our overall score: 55/100 against 47/100
- domain rating: 13/100 against 0/100
At a glance
| Measure | Beam Therapeutics | Cassidy Bio |
|---|---|---|
| What it is | A biotechnology company developing precision genetic medicines through base editing technology to treat a broad range of diseases. | Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions. |
| Category | Workflows, Biotech, MedTech, Genomics | Workflows, Biotech, Genomics, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Platform |
| Founded | 2017 | 2023 |
| Headquarters | Cambridge, United States | Not published |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Beam Therapeutics | Cassidy Bio |
|---|---|---|
| Employees | Not published | 15 |
| Headcount growthLast 12 months | Not published | -67.0% |
| Total funding | $235M | $20.0M |
| Latest round | Series C | Seed |
| LinkedIn followers | Not published | 1,252 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Beam Therapeutics | Cassidy Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 47/100 | 55/100 |
| Traction | 40/100 | 49/100 |
| Team | Not published | 70/100 |
| Search visibility | 2/100 | 37/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (31/100) |
| Domain ratingLink authority, 0-100 | 0/100 | 13/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Beam Therapeutics | Cassidy Bio |
|---|---|---|
| CDN | Not detected | Cloudflare |
| CMS | Not detected | Webflow |
| Analytics | Not detected | Google Tag Manager |
Product and pricing
| Measure | Beam Therapeutics | Cassidy Bio |
|---|---|---|
| Key features | Not published | gRNA design, Accelerate, Expand & Optimize, De-Risk |
Beam Therapeutics vs Cassidy Bio: common questions
Which is better, Beam Therapeutics or Cassidy Bio?
On our 0-100 score Cassidy Bio rates higher (55/100 against 47/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Beam Therapeutics and Cassidy Bio compare on the numbers?
Beam Therapeutics leads on funding raised ($235M against $20.0M). Cassidy Bio leads on our overall score (55/100 against 47/100), domain rating (13/100 against 0/100).
Read the full Beam Therapeutics review and pricing or the Cassidy Bio review and pricing. You can also browse other Beam Therapeutics alternatives we track.